Regulation of human apolipoprotein A-l gene expression by equine estrogens

Journal of Lipid Research

Volumn 42, Issue 11, 2001, Pages 1789-1800

  Zhang, X ^a   Jiao, J J ^a   Bhavnani, B R ^a   Tam, S P ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Apolipoprotein A I; Estrogen replacement therapy; Gene regulation; HDL

Indexed keywords

APOLIPOPROTEIN A1; CONJUGATED ESTROGEN; EQUILENIN; ESTROGEN; ESTROGEN RECEPTOR; HIGH DENSITY LIPOPROTEIN;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA DETERMINATION; DNA PROTEIN COMPLEX; ESTROGEN THERAPY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; TRANSCRIPTION REGULATION;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; CARCINOMA, HEPATOCELLULAR; EQUILENIN; ESTROGEN ANTAGONISTS; ESTROGENS; GENE EXPRESSION REGULATION; HORSES; HUMANS; KINETICS; LIVER NEOPLASMS; LUCIFERASES; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035199904     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Epidemiology and risk factors for coronary heart disease in women
2. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population
3. The pathogenesis of atherosclerosis - An update
4. Koch's postulates for cholesterol
5. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
6. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women
7. Therapeutic controversy: Estrogen replacement in menopause
8. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
9. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration
10. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
11. Estrogen and coronary heart disease in women
12. Mechanisms of cardiovascular protection by postmenopausal hormone replacement therapy
13. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
14. Effects of hormone replacement therapy on the endometrium and lipid parameters: A review of randomized clinical trials, 1985 to 1995
15. Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit
16. Beyond low-density lipoprotein cholesterol. A perspective on low high-tensity lipoprotein disorders and Lp (a) lipoprotein excess
17. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
18. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein
19. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
20. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
21. Tissue-specific expression of apolipoprotein A-I (apoA-I) is regulated by the 5′-flanking region of the human apoA-I gene
22. Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily
23. Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types
24. Regulation of human apolipoprotein A-I gene expression by gramoxone
25. Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing
26. Estradiol stimulates apolipoprotein A-I- but not A-II-containing particle synthesis and secretion by stimulating mRNA transcription rate in Hep G2 cells
27. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta
28. A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines
29. Mechanism of cytochrome P450-catalyzed aromatic hydroxylation of estrogens
30. Effects of dimethyl sulfoxide on apolipoprotein A-I in the human hepatoma cell line, HepG2
31. Antioxidant potential of specific estrogens on lipid peroxidation
32. Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein
33. Are cardiovascular benefits associated with conjugated equine estrogen therapy and red wine consumption - A result of the antioxidant properties of their components?
34. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: Chemistry and metabolism
35. Effects of estrogen on apolipoprotein secretion by the human hepatocarcinoma cell line, HepG2
36. Human S mu binding protein-2 binds to the drag response element and transactivates the human apoA-I promoter: Role of gemfibrozil
37. Protein-DNA interactions at a drug-responsive element of the human apolipoprotein A-I gene
38. Effect of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma (HepG2) cells
39. Regulation of apolipoprotein A-I gene expression by phenobarbital in the hepatocarcinoma cell line, Hep3B
40. Neuroprotective effects of equine estrogens against oxodozed LDL-induced neuronal cell death
41. Regulation of hepatic apolipoprotein synthesis in the 17 alpha-ethinyl estradiol-treated rat
42. In vivo regulation of apolipoprotein A-I gene expression by estradiol and testosterone occurs by different mechanisms in inbred strains of mice
43. Estrogen up-regulates apolipoprotein E (apoE) gene expression by increasing apoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway
44. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity
45. Antioxidant and redox regulation of gene transcription
46. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites
47. Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: Mechanism of antagonism by testosterone
48. Interaction of ring B unsaturated estrogens with estrogen receptors of human endometrium and rat uterus
49. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer
50. The quinone reductase gene: A unique estrogen receptor-regulated gene that is activated by antiestrogens
51. Characterization of an enhancer element in the human apolipoprotein C-III gene that regulates human apolipoprotein A-I gene expression in the intestinal epithelium
52. The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and apoA-IV is regulated by two common enhancers
53. A bifunctional regulatory element of the human apoA-I gene responsive to a distal enhancer